Loxo Oncology, Inc. Research and Development Expense
Loxo Oncology, Inc. reported Research and Development Expense of $56.93 million for the 3-month period ending 2018-09-30, per its 10-Q filed 2018-11-08.
Discontinued › Expense Statement › Operating Expenses
us-gaap:ResearchAndDevelopmentExpense · last filed 2018-11-08
- Loxo Oncology, Inc. research and development expense for the quarter ending 2018-09-30 was $56.93M, a 12.09% decline year-over-year.
- Loxo Oncology, Inc. research and development expense for the quarter ending 2018-06-30 was $41.55M, a 70.32% increase year-over-year.
- Loxo Oncology, Inc. research and development expense for the quarter ending 2018-03-31 was $31.99M, a 58.61% increase year-over-year.
- Loxo Oncology, Inc. research and development expense for the quarter ending 2017-12-31 was $30.72M, a 31.51% increase year-over-year.
- Loxo Oncology, Inc. research and development expense for fiscal 2017 was $140.04M, a 140.31% increase from fiscal 2016.
- Loxo Oncology, Inc. research and development expense for fiscal 2016 was $58.27M, a 317.56% increase from fiscal 2015.
- Loxo Oncology, Inc. research and development expense for fiscal 2015 was $13.96M, a 100.89% increase from fiscal 2014.
- Loxo Oncology, Inc. research and development expense for fiscal 2014 was $6.95M.
| Period end | Research and Development Expense 2 month | Research and Development Expense 3 month | Research and Development Expense 3 month as first filed | Research and Development Expense 5 month | Research and Development Expense 6 month | Research and Development Expense 6 month as first filed | Research and Development Expense 8 month | Research and Development Expense 9 month | Research and Development Expense 9 month as first filed | Research and Development Expense 12 month |
|---|---|---|---|---|---|---|---|---|---|---|
| 2018-09-30 | $56.93M 10-Q · filed 2018-11-08 | $98.48M derived: sum of 2 quarters · filed 2018-11-08 | $130.47M 10-Q · filed 2018-11-08 | $161.19M derived: sum of 4 quarters · filed 2018-11-08 | ||||||
| 2018-06-30 | $41.55M 10-Q · filed 2018-08-09 | $73.55M 10-Q · filed 2018-08-09 | $104.26M derived: sum of 3 quarters · filed 2018-08-09 | $169.02M derived: sum of 4 quarters · filed 2018-11-08 | ||||||
| 2018-03-31 | $31.99M 10-Q · filed 2018-05-08 | $62.71M derived: sum of 2 quarters · filed 2018-05-08 | $127.46M derived: sum of 3 quarters · filed 2018-11-08 | $151.86M derived: sum of 4 quarters · filed 2018-11-08 | ||||||
| 2017-12-31 | $30.72M derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-01 | $95.47M derived: sum of 2 quarters · filed 2018-11-08 | $119.87M derived: sum of 3 quarters · filed 2018-11-08 | $140.04M 10-K · filed 2018-03-01 | ||||||
| 2017-09-30 | $64.75M 10-Q · filed 2018-11-08 | $89.15M derived: sum of 2 quarters · filed 2018-11-08 | $109.32M 10-Q · filed 2018-11-08 | $132.68M derived: sum of 4 quarters · filed 2018-11-08 | ||||||
| 2017-06-30 | $24.40M 10-Q · filed 2018-08-09 | $44.57M 10-Q · filed 2018-08-09 | $67.92M derived: sum of 3 quarters · filed 2018-08-09 | $82.16M derived: sum of 4 quarters · filed 2018-08-09 | ||||||
| 2017-03-31 | $20.17M 10-Q · filed 2018-05-08 | $43.53M derived: sum of 2 quarters · filed 2018-05-08 | $57.76M derived: sum of 3 quarters · filed 2018-05-08 | $70.09M derived: sum of 4 quarters · filed 2018-05-08 | ||||||
| 2016-12-31 | $23.36M derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-01 | $37.59M derived: sum of 2 quarters · filed 2018-03-01 | $49.92M derived: sum of 3 quarters · filed 2018-03-01 | $58.27M 10-K · filed 2018-03-01 | ||||||
| 2016-09-30 | $14.23M 10-Q · filed 2017-11-02 | $26.56M derived: sum of 2 quarters · filed 2017-11-02 | $34.92M 10-Q · filed 2017-11-02 | $40.78M derived: sum of 4 quarters · filed 2018-03-01 | ||||||
| 2016-06-30 | $12.33M 10-Q · filed 2017-08-08 | $20.69M 10-Q · filed 2017-08-08 | $26.55M derived: sum of 3 quarters · filed 2018-03-01 | $29.93M derived: sum of 4 quarters · filed 2018-03-01 | ||||||
| 2016-03-31 | $8.36M 10-Q · filed 2017-05-09 | $14.22M derived: sum of 2 quarters · filed 2018-03-01 | $17.60M derived: sum of 3 quarters · filed 2018-03-01 | $20.40M derived: sum of 4 quarters · filed 2018-03-01 | ||||||
| 2015-12-31 | $5.86M derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-01 | $9.25M derived: sum of 2 quarters · filed 2018-03-01 | $12.04M derived: sum of 3 quarters · filed 2018-03-01 | $13.96M 10-K · filed 2018-03-01 | ||||||
| 2015-09-30 | $3.39M 10-Q · filed 2016-11-02 | $6.18M derived: sum of 2 quarters · filed 2016-11-02 | $8.10M 10-Q · filed 2016-11-02 | $10.50M derived: sum of 4 quarters · filed 2017-03-07 | ||||||
| 2015-06-30 | $2.79M 10-Q · filed 2016-08-03 | $4.71M 10-Q · filed 2016-08-03 | $7.11M derived: sum of 3 quarters · filed 2017-03-07 | $9.82M derived: sum of 4 quarters · filed 2017-03-07 | ||||||
| 2015-03-31 | $1.92M 10-Q · filed 2016-05-04 | $4.32M derived: sum of 2 quarters · filed 2017-03-07 | $7.03M derived: sum of 3 quarters · filed 2017-03-07 | $8.05M derived: sum of 4 quarters · filed 2017-03-07 | ||||||
| 2014-12-31 | $2.40M derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-07 | $5.11M derived: sum of 2 quarters · filed 2017-03-07 | $6.13M derived: sum of 3 quarters · filed 2017-03-07 | $6.95M 10-K · filed 2017-03-07 | ||||||
| 2014-09-30 | $2.71M 10-Q · filed 2015-11-10 | $2.62M 10-Q · filed 2014-11-14 | $3.73M derived: sum of 2 quarters · filed 2015-11-10 | $4.54M 10-Q · filed 2015-11-10 | $4.41M 10-Q · filed 2014-11-14 | |||||
| 2014-06-30 | $1.02M 10-Q · filed 2015-08-05 | $855.00K 10-Q · filed 2014-10-07 | $1.79M 10-Q · filed 2015-08-05 | $1.57M 10-Q · filed 2014-10-07 | ||||||
| 2014-03-31 | $767.00K 10-Q · filed 2015-05-14 | |||||||||
| 2013-12-31 | $323.00K 10-K · filed 2015-03-27 | |||||||||
| 2013-09-30 | $37.00K 10-Q · filed 2014-11-14 | $43.00K 10-Q · filed 2014-11-14 | ||||||||
| 2013-06-30 | $6.00K 10-Q · filed 2014-10-07 |